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ABSTRACT
Background. DSM-IV criteria for illicit drug abuse and dependence are largely based on criteria
developed for alcohol use disorders and there is a lack of research evidence on the psychometric
properties of these symptoms when applied to illicit drugs.
Method. This study utilizes data on abuse/dependence criteria for cannabis, cocaine, stimulants,
sedatives, tranquilizers, opiates, hallucinogens and inhalants from the National Epidemiological
Survey on Alcohol and Related Conditions (NESARC, n=43 093). Analyses included factor ana-
lysis to explore the dimensionality of illicit drug abuse and dependence criteria, calculation of
item diﬃculty and discrimination within an item response framework and a descriptive analysis of
‘diagnostic orphans’ : individuals meeting criteria for 1–2 dependence symptoms but not abuse.
Rates of psychiatric disorders were compared across groups.
Results. Results favor a uni-dimensional construct for abuse/dependence on each of the eight drug
classes. Factor loadings, item diﬃculty and discrimination were remarkably consistent across drug
categories. For each drug category, between 29% and 51% of all individuals meeting criteria for at
least one symptom did not receive a formal diagnosis of either abuse or dependence and were
therefore classiﬁed as ‘orphans’. Mean rates of disorder in these individuals suggested that illicit
drug use disorders may be more adequately described along a spectrum of severity.
Conclusions. While there were remarkable similarities across categories of illicit drugs, consider-
ation of item diﬃculty suggested that some alterations to DSM regarding the relevant severity of
speciﬁc abuse and dependence criteria may be warranted.
INTRODUCTION
Within the past several decades, there has been a
dramatic increase in the prevalence of illicit drug
use (Johnson & Gerstein, 1998; Degenhardt
et al. 2000). While cannabis remains the most
commonly used illicit drug, substantial min-
orities of people also report the use of other
illicit drugs. For example, among people aged
12 years and older in the U.S., it has been esti-
mated that 46.4% have ever used cannabis,
14.7% have ever used cocaine, 1.6 have used
heroin, 14.5% have used hallucinogens, 9.7%
have used inhalants and 20.1% have ever
used prescribed pharmaceuticals non-medically
(Substance Abuse and Mental Health Services
Administration, 2004).
While many people who use illicit drugs may
do so only infrequently, there are a substantial
proportion of users who go on to develop a
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range of problems as a consequence of their
illicit drug use. Within the DSM (APA, 1994)
system of nomenclature, such problems are as-
sessed using criteria for substance abuse and/or
substance dependence, the criteria for which are
largely based on those derived for alcohol
(Edwards & Gross, 1976). Despite their wide-
spread application, the appropriateness of these
criteria for assessing abuse and dependence
across a spectrum of illicit drugs with distinct
pharmacological properties remains question-
able, yet relatively under-researched (Budney,
2006; Hughes, 2006).
In particular, within the alcohol and, to a
lesser extent, cannabis literature there have been
multiple studies that have examined issues re-
lating to the dimensionality of alcohol use dis-
orders using methods of factor analysis, item
response modeling and more recently, taxo-
metric techniques (e.g. mean above minus
below a cut – MAMBAC). Factor analysis is
the critical ﬁrst step to addressing concerns
surrounding dimensionality. This method is ex-
ploratory and can be used to test whether
abuse and dependence form distinct abuse and
dependence factors (which, may or may not be
orthogonal) or whether all criteria load on a
single (uni-dimensional) factor. Item response
models are comparable to this latter, single
conﬁrmatory single-factor model, in that they
assume that there is a uni-dimensional construct
underlying abuse and dependence criteria and
that given an individual’s liability (or factor
score), they are more or less likely to endorse
certain criteria. Taxometric techniques, on the
other hand, test the hypothesis of whether
the covariation between abuse and dependence
criteria is indicative of a latent structure that
is dimensional or categorical/taxonic (Meehl,
1995). Other ‘aggregative’ techniques, such as
latent class analysis (McCutcheon, 1987) and
cluster analysis (Tyron, 1939) have also been
applied.
There have been several studies testing the
applicability of dependence criteria to illicit
drug-related problems, although the bulk of
these have been based on the analysis of data
from clinical or other selected populations.
Furthermore, they have produced inconsistent
results, with some studies supporting the coher-
ence of dependence (Hasin et al. 1988; Mor-
genstern et al. 1994; Feingold & Rounsaville,
1995; Nelson et al. 1999; Swift et al. 2001;
Langenbucher et al. 2004) while others have
identiﬁed multiple factors underlying depen-
dence criteria (e.g. Kosten et al. 1987). Ad-
ditionally, these studies have typically examined
dependence criteria only and have not con-
sidered the psychometric properties of criteria
for illicit drug abuse. One study did, however,
report that there is a single dimension under-
lying cannabis abuse and dependence criteria
(Teesson et al. 2002), although examination of
item characteristic curves [calculated using item
response theory (IRT) criterion characteristic
curves (Muthen & Lehman, 1985)] suggested
some discrepancies between item properties and
the DSM conceptualization. Speciﬁcally, several
of the dependence criteria discriminated be-
tween people with relatively low degrees of
cannabis-related problems while conversely,
several of the abuse items discriminated at a
high level of cannabis-related problems. We
have previously tested factor models for canna-
bis abuse and dependence criteria in NESARC
(Agrawal & Lynskey, in press) and reported
similar results to those from the Australian
study by Teesson et al. (2002). A shortcoming
of this extant literature is that relatively little
attention has been paid to similarities and dif-
ferences in the factor structure and/or criterion
responses across classes of drugs (Gillespie
et al. in press). It is likely, that this limitation
is in large part due to the low prevalence of
abuse/dependence of some illicit drugs.
A further issue concerning the dimensionality
of substance use disorders centers on ‘diagnostic
orphans’ – individuals who do not meet criteria
for abuse or for dependence but who do endorse
one or two dependence criteria. Concerns have
been raised that such individuals may experi-
ence signiﬁcant substance-related problems but,
because of the diagnostic conventions of the
DSM system, do not meet criteria for a sub-
stance use disorder. To date, the majority of
studies examining this aspect of nomenclature
appear to have focused on alcohol (Hasin &
Paykel, 1998, 1999; Pollock & Martin, 1999;
Sarr et al. 2000; Eng et al. 2003) while only one
study has examined this issue in relationship to
cannabis use disorders (Degenhardt et al. 2002).
A consideration of this literature suggests sev-
eral conclusions: ﬁrst, the percentage of in-
dividuals who meet criteria for at least one
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dependence symptom but who are labeled as
orphans appears quite high: between 13.7%
and 41.1% for alcohol (Pollock & Martin,
1999; Sarr et al. 2000; Eng et al. 2003) and an
estimated 21% for cannabis (Degenhardt et al.
2002). While, to the best of our knowledge, no
previous study has examined the prevalence and
characteristics of ‘diagnostic orphans’ for other
illicit substance use, the consistency of ﬁndings
between alcohol and cannabis suggests that a
substantial proportion of people meeting at
least one criteria for an illicit drug problem may
be labeled as ‘diagnostic orphans’ and that such
individuals may be at heightened risks for drug-
related and other mental health problems, rela-
tive to individuals experiencing no abuse or
dependence criteria.
Closely related to the concept of ‘diagnostic
orphans’ are issues relating more broadly to
the dimensional or categorical nature of sub-
stance use disorders. Current conventions
assign classiﬁcations of ‘dependent’ or ‘non-
dependent’ yet there is likely to be a spectrum of
symptom severity. For instance, Grant et al.
(2006) have shown that the latent classes ident-
iﬁed for cannabis use disorders are representa-
tive of a spectrum of severity and that they do
not distinguish classes of individuals with abuse
or dependence. A recent taxometric study by
Denson & Earleywine (2006) has also shown
that a dimensional interpretation of cannabis
dependence is favored over a taxonic one. While
our discussion of diagnostic orphans addresses
issues relating to individuals who have 1–2
dependence symptoms and therefore do not
meet formal criteria for abuse or dependence,
it is also the case that, among those meeting
criteria for abuse (but not dependence), there
may be gradations of severity with some in-
dividuals meeting criteria for abuse only while
others meet criteria for abuse as well as 1–2
dependence symptoms. Similarly, among in-
dividuals meeting criteria for dependence, some
may also exhibit symptoms of abuse while
others do not.
Against this general background, we use data
from a large and representative sample of the
U.S. general population – the National Epi-
demiologic Survey on Alcohol and Related
Conditions (NESARC; Grant et al. 2003b) to
examine a number of issues related to the psy-
chometric properties of DSM-IV assessments of
illicit drug use symptomatology. First, we
examine the factor structure of illicit drug use
disorders (cannabis, cocaine, sedatives, tran-
quilizers, stimulants, hallucinogens, opiates and
inhalants). Second, we report diﬃculty and dis-
crimination parameters from an item response
analysis of the individual abuse and dependence
criteria for each illicit drug class. Third, we ex-
plore the spectrum of illicit drug symptoma-
tology and the extent to which this spectrum of
severity covaries with diagnoses of common
mental health problems, including major de-
pressive disorder, generalized anxiety disorder,
panic disorder (with or without agoraphobia),
speciﬁc phobias, social phobia, antisocial per-




The NESARC is a nationally representative
sample of 43 093 participants aged 18–99 years.
Comprehensive details regarding the survey
design and sample characteristics are available
elsewhere (Grant et al. 2003b). Collected during
2001–2002 by the U.S. Bureau of Census on
behalf of the National Institute on Alcohol
Abuse and Alcoholism, the sample includes
data from adult, non-institutionalized U.S. citi-
zens and non-citizens (including Alaska and
Hawaii). Approximately 57% of the sample
is female and 19% of the sample is Hispanic
(76% Caucasian), with an over-sampling for
non-Hispanic Black households and for young
adults aged 18–24 years. After complete
description of the study to the subjects, in-
formed consent was obtained. Statements re-
garding the strict conﬁdentiality of respondent
privacy are available at http://niaaa.census.gov/
conﬁdentiality.html.
Measures
The Alcohol Use Disorder and Associated
Disabilities Schedule (AUDADIS-IV) module
was used for interviews (Grant et al. 2003a).
Individual DSM-IV criteria (APA, 1994) of
illicit drug abuse and dependence were assessed
for their occurrence in the last 12 months and in
the period prior to those last 12 months only
in those who reported lifetime illicit drug use.
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Illicit drug categories assessed in this interview
were: cannabis, cocaine, stimulants, sedatives,
tranquilizers, opiates, hallucinogens and inhal-
ants.
A lifetime endorsement of each of the four
abuse and seven dependence criteria was created
by combining across the 12-month and prior
to 12-month endorsements. Criteria for abuse
included: (i) Legal (legal problems/getting
arrested) ; (ii) Failure (failure to fulﬁll major
role obligations) ; (iii) Hazard (use in hazardous
situations) ; and (iv) Continue (continued
use despite trouble with friends or family).
Criteria for dependence included: (i) Tolerance ;
(ii) Withdrawal ; (iii) Intend (using larger
amounts/for longer than intended); (iv) Give up
(give up or cut down on important activities) ;
(v) Problems (use of drug despite health/
psychological problems) ; (vi) Time (spent time
getting or using drug); and (vii) Quit (more than
once trying to stop or cut down use of drug).
The assessment of alcohol and illicit drug use
disorders using the AUDADIS has been de-
tailed previously (Stinson et al. 2005; Dawson
et al. 2005).
Statistical analyses
One- and two-factor (orthogonal and oblique)
conﬁrmatory models (CFA) were ﬁtted to data
for abuse and dependence criteria for each of the
eight illicit drug classes. Model-ﬁtting was per-
formed in MPlus (v4; Muthen & Muthen, 2006)
using the robust maximum-likelihood ratio
(MLR) estimator, which is suited to the analysis
of data from complex survey designs and for
missing data analyses, such as criterion data in
those who had never used the substance.
Criterion data for every individual who had re-
sponded to the lifetime use question for each
drug was used and lifetime non-users were as-
signed a missing value. Data were weighted,
clustered on primary sampling units (PSU) and
appropriately stratiﬁed to allow generalizability
to the U.S. population. NESARC weights are
computed as a product of the base weight
(product of conditional probabilities of selec-
tion of PSU within stratum and of housing unit
within PSU) and of individual weighting factors
(e.g. usual residence elsewhere adjustments).
Details regarding weight estimates, selection of
sampling units and stratiﬁcation are available in
Grant et al. (2003b).
One advantage of using the MPlus (v4) soft-
ware (Muthen & Muthen, 2006) is that it allows
the computation of item response parameters
(Birnbaum, 1968) by default for a one-factor
CFA. Criterion diﬃculty and discrimination,
which are key to the conceptualization of an
item response model, were computed using a
2-parameter (2P) logistic model with logit func-
tion L=1.7*a(hxb), where a=discrimination,
or the ability of a criterion to distinguish in-
dividuals with high liability from individuals
with low liability ; b=diﬃculty, or the location
along the underlying distribution where the cri-
terion functions; and h=the liability distri-
bution for each substance use disorder.
Parameters from the CFA can be easily con-
verted to discrimination and diﬃculty par-
ameters (Muthen, 1985; Takane & de Leeuw,
1987; MacIntosh & Hashim, 2003). For in-
stance ‘a ’ or discrimination is representative
of the factor loading, or whether a criterion
is overall a good indicator of the underlying
factor structure. The criterion discrimination
parameter may be computed by multiplying the
parameter estimate for that criterion with the
square root of the factor variance and dividing
the product by a constant 1.7 to approximate
the probit scale. Likewise, ‘b ’ or diﬃculty is
a location index or representative of the thresh-
old of an individual criterion along the liability
distribution. It is computed by dividing the
standardized threshold by the factor loading.
In other words, criterion diﬃculty reﬂects the
proportion of individuals endorsing the cri-
terion. A diﬃcult (or hard ) criterion has a higher
threshold (i.e. is endorsed by fewer people) and
is less likely to be endorsed than an easy cri-
terion.
Note that we opted to use the 2P model,
where P(h), the probability of endorsing a
criterion at a given liability level, was computed
as P(h)=1/1+exp(xL), where L=1.7*a(hxb)
(see also the technical appendix available at
http://www.statmodel.com/download/MplusIRT1.
pdf). An alternative, more parsimonious model,
the 1-parameter (Rasch, 1960, 1966) model is
also possible, where all criteria are assumed to
discriminate equally. We tested this model
across all substances by constraining the factor
loadings (i.e. equal discriminations) across cri-
teria for each substance. In all cases, this con-
straint led to a serious deterioration of model ﬁt.
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For instance, for cannabis use disorders, the
diﬀerence in log-likelihood ﬁt for the Rasch
model (with 12 parameters=11 thresholds and 1
loading) and the 2P model (with 22 para-
meters=11 thresholds+11 loadings) was 381.5
(for 10 df, p value <0.0001). Similarly, for co-
caine use disorders, the deterioration in ﬁt with
the Rasch model was 217.7. Therefore, we pur-
sued the 2P model for our analyses.
RESULTS
Conﬁrmatory factor models of abuse and
dependence criteria
Table 1 summarizes the ﬁt indices for one- and
two-factor models and the estimated inter-
factor correlation derived from the two-factor
model for each of the eight illicit drug categor-
ies. While, across each of the eight drug classes,
the two-factor model provided a better ﬁt to the
data, the estimated inter-factor correlations
were exceptionally high, ranging from 0.77 for
sedatives to 0.92 for cannabis. The improvement
in model ﬁt associated with the two-factor
model may be partially a function of large
sample size (Bentler, 1990). With larger samples,
especially those as large as NESARC, trivial
rejections of more parsimonious models (i.e. in
favor of more saturated models) can occur.
Given this, and the high inter-factor correla-
tions, the observed pattern of results are con-
sistent with the conclusion that there is a single
continuum of severity underlying the abuse and
dependence criteria for each of the eight drug
classes, overlaid by correlated error structure.
The factor loadings from one-factor models
of abuse and dependence for each of the eight
drug categories are summarized in Table 2.
These analyses produced a consistent pattern of
results : The factor loadings were uniformly high
and there also appeared to be considerable
consistency in the relative magnitude of the
loadings for each item across substances.
Item response models
Assuming a one-factor model for substance use
disorders, item response characteristics were
also obtained to depict criterion function.
Tables 3a and 3b summarize the discrimination
and diﬃculty parameters for each criterion
across each drug category derived from the re-
sults of a series of 2P item response models.
Note that diﬃculty parameters are a function of
both factor loadings (from Table 2) and thresh-
olds, while the discrimination parameter is de-
rived from unstandardized estimates of the
factor loading and the variance of the underly-
ing factor. There was broad consistency of par-
ameter estimates across substance use categories
and a number of interesting observations stem
from Tables 3a and 3b. First, it appears that
certain criteria have poor discriminative value,
regardless of drug class. The most prominent
examples of this are the abuse criteria of ‘ legal
diﬃculties ’ and ‘hazardous use’, and the de-
pendence criterion of ‘trying but being unable to
quit ’. Second, the results are particularly no-
table for the relative diﬃculties of abuse versus
dependence criteria. Despite abuse theoretically
representing a less severe manifestation of sub-
stance use disorders, the ‘ legal diﬃculties ’ cri-
terion had the highest criterion diﬃculty across
each of the eight drug categories studied.
Conversely, despite its designation as an indi-
cator of dependence, the symptom of ‘trying but
being unable to quit ’ consistently had the lowest
criterion diﬃculty for each drug category. Thus,
the overall pattern of criterion diﬃculty did not
appear to support DSM speciﬁcations of the
relative severity of abuse and dependence symp-
toms.
Prevalence of illicit drug use disorders and
symptomatology
Table 4 shows the prevalence of illicit drug use
and symptomatology for the eight drug classes.
Table 1. Log likelihood model ﬁt for one- and
two-factor models, and estimated inter-factor





Cannabis x49409.0 x49356.4 0.92 (0.90–0.95)
Cocaine x19759.8 x19700.1 0.91 (0.89–0.94)
Stimulants x15189.8 x15115.8 0.86 (0.82–0.91)
Sedatives x12012.4 x11926.6 0.77 (0.71–0.85)
Tranquilizers x10326.8 x10261.2 0.82 (0.75–0.88)
Opiates x14013.0 x13974.0 0.88 (0.83–0.93)
Hallucinogens x16201.4 x16159.8 0.87 (0.82–0.93)
Inhalants x5426.2 x5406.1 0.81 (0.70–0.93)
The two-factor model requires 2 degrees of freedom.
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The most commonly used illicit drug was can-
nabis (20.7%) and the least commonly used was
inhalants (1.7%) while other drug categories
were used by between 3.4% and 6.2% of the
sample. The information contained in this table
can also be used to calculate the proportion
of users, and of those meeting criteria for
any abuse or dependence symptom, who were
Table 2. Standardized factor loadings for illicit substance abuse and dependence criteria
Dependence criteria Abuse criteria
Tolerance Withdrawal Intend Quit Time Give up Problems Failure Legal Hazard Continue
Cannabisa 0.84 0.85 0.82 0.54 0.86 0.90 0.82 0.83 0.61 0.68 0.76
Cocaine 0.86 0.89 0.90 0.64 0.93 0.93 0.92 0.88 0.65 0.72 0.83
Hallucinogens 0.78 0.89 0.85 0.53 0.85 0.88 0.81 0.86 0.69 0.70 0.80
Opiates 0.85 0.85 0.80 0.57 0.88 0.80 0.84 0.81 0.61 0.70 0.74
Stimulants 0.85 0.83 0.88 0.57 0.91 0.87 0.88 0.83 0.65 0.63 0.78
Sedatives 0.80 0.84 0.80 0.57 0.88 0.85 0.83 0.81 0.72 0.70 0.77
Tranquilizers 0.86 0.86 0.89 0.64 0.92 0.86 0.89 0.87 0.74 0.72 0.83
Inhalants 0.86 0.72 0.84 0.57 0.88 0.89 0.87 0.87 0.81 0.74 0.81
All factor loadings are statistically signiﬁcant (p<0.0001).
a These estimates though similar to those previously reported in Agrawal & Lynskey (in press) involve a diﬀerent methodological strategy.
Table 3(a). Item discrimination parameters for illicit substance abuse and dependence criteria
Dependence criteria Abuse criteria
Tolerance Withdrawal Intend Quit Time Give up Problems Failure Legal Hazard Continue
Cannabis 1.67 1.75 1.54 0.69 1.79 2.22 1.51 1.56 0.82 0.99 1.23
Cocaine 1.84 2.11 2.21 0.90 2.62 2.64 2.55 1.95 0.92 1.11 1.58
Hallucinogens 1.31 1.93 1.70 0.66 1.67 1.86 1.49 1.73 1.01 1.02 1.39
Opiates 1.71 1.75 1.42 0.75 1.94 1.40 1.63 1.47 0.82 1.05 1.16
Stimulants 1.75 1.60 1.95 0.74 2.36 1.87 1.78 1.59 0.90 0.87 1.26
Sedatives 1.44 1.63 1.42 0.74 1.95 1.71 1.60 2.49 1.14 1.03 1.29
Tranquilizers 1.81 1.76 2.13 0.89 2.47 1.74 2.03 1.76 1.18 1.11 1.57
Inhalants 1.80 1.12 1.69 0.74 1.93 2.08 1.86 1.88 1.45 1.16 1.48
Item discrimination is calculated as the unstandardized parameter estimate for the factor loading multiplied by the square root of the total
factor variance and the product divided by 1.7 to approximate the probit scale. For instance, for the hazard criterion for cocaine use disorders,
the unstandardized parameter estimate for the factor loading was 0.60, the total variance in the factor representing cocaine use disorders was
9.70, and therefore item discrimination=(0.601*d9.70)/1.7, which gives 1.11. The discrimination parameter reﬂects the extent to which the
criterion distinguishes between individuals with relatively higher versus lower liability. In item characteristic curves, discrimination=slope.
Table 3(b). Item diﬃculty parameters for illicit substance abuse and dependence criteria
Dependence criteria Abuse criteria
Tolerance Withdrawal Intend Quit Time Give up Problems Failure Legal Hazard Continue
Cannabis 1.51 2.18 1.71 0.76 1.39 1.77 1.52 1.66 2.53 0.61 1.30
Cocaine 1.05 1.41 1.00 0.17 0.72 0.12 0.86 1.17 2.32 0.59 0.63
Hallucinogens 1.86 2.31 1.84 0.84 1.63 1.88 1.73 1.68 2.93 1.12 1.31
Opiates 1.42 1.95 1.58 0.91 1.43 2.10 1.65 1.75 3.35 1.13 1.42
Stimulants 1.21 1.62 1.29 0.50 1.13 1.55 1.14 1.42 2.57 0.73 0.89
Sedatives 1.69 2.07 1.74 0.81 1.55 1.89 1.62 1.73 2.51 1.29 1.31
Tranquilizers 1.62 1.97 1.51 0.78 1.45 1.88 1.53 1.62 2.54 1.15 1.16
Inhalants 2.07 3.00 1.99 0.86 1.67 1.96 1.72 1.65 2.93 1.57 1.48
Item diﬃculty was computed as the standardized threshold/factor loading from Table 2. Therefore, to obtain the diﬃculty for say, the
Hazard criterion for cocaine use disorders, we would divide threshold/0.72=0.59; or standardized threshold=0.43.
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categorized as ‘diagnostic orphans’ or who met
full criteria for abuse or dependence.
A considerable proportion of lifetime users
met criteria for at least one symptom of abuse or
dependence: 40% of lifetime users of inhalants
met criteria for at least one symptom of abuse/
dependence while 69% of lifetime cocaine users
met criteria for at least one symptom. The
probabilities of experiencing any symptom of
abuse/dependence for the other drug classes
varied between these extremes.
Importantly, a relatively high proportion of
those reporting at least one symptom did not
meet formal diagnostic criteria for abuse or de-
pendence, and were therefore labeled as ‘diag-
nostic orphans’ : this varied from 29% for
cocaine and stimulants to 51% for inhalants.
There was also further evidence of a spectrum
of symptomatology with between 39% (for in-
halants) and 49% (for cannabis) of those who
received a formal diagnosis of abuse also meet-
ing criteria for one or two dependence criteria.
Finally, among those meeting criteria for de-
pendence on any speciﬁc drug class, a very high
proportion (between 74% and 94%) also met
criteria for abuse.
Table 5 shows the mean number of co-morbid
DSM-IV psychiatric disorders [major depressive
disorder, generalized anxiety disorder, panic
disorder (with or without agoraphobia), speciﬁc
phobias, social phobia, antisocial personality
disorder, alcohol abuse/dependence and nic-
otine dependence] across the above categories of
symptomatology. Due to the small number of
individuals meeting criteria for dependence but
not abuse, the ﬁnal column of this table includes
all individuals meeting criteria for dependence,
regardless of whether or not they also met cri-
teria for abuse. Rates of psychiatric disorders
were substantially lower in those who had never
used a speciﬁc drug than in users (regardless
of whether they endorsed any symptoms).
Additionally, lowest mean rates of disorder oc-
curred in users who reported no abuse or de-
pendence symptomatology. Diagnostic orphans
had elevated rates of psychopathology although
these were approximately equal to or less than
rates among those meeting criteria for abuse.
Interestingly, there appeared to be no con-
sistent diﬀerence in rates of psychopathology in
people meeting criteria for abuse, depending on
whether they also reported one or two depen-
dence symptoms. Finally, individuals meeting
criteria for dependence had the highest mean
rates of psychopathology.
DISCUSSION
In this paper we have explored a number of
issues relating to the criterion performance of
DSM-IV symptoms for illicit substance use dis-
orders, as well as issues relating to the classiﬁ-
cation and dimensionality of these disorders.
Despite the widespread application of these cri-
teria to illicit substance use, these issues have
been relatively unexplored (Budney, 2006;
Hughes, 2006), doubtless due to the large sam-
ple sizes needed to examine them. We have been
able to capitalize on the extremely large sample
size of NESARC, enabling us to examine these


















Cannabisb 79.27 8.61 3.59 3.67 3.56 0.10 1.21
Cocaine 93.80 2.22 1.14 0.97 0.87 0.06 0.93
Hallucinogens 94.14 2.87 1.28 0.80 0.67 0.03 0.21
Opiates 95.22 2.43 0.91 0.60 0.49 0.06 0.28
Stimulants 95.30 1.85 0.83 0.75 0.66 0.07 0.53
Sedatives 95.6 2.14 0.91 0.44 0.40 0.06 0.18
Tranquilizers 96.55 1.79 0.67 0.43 0.33 0.06 0.17
Inhalants 98.31 1.02 0.39 0.19 0.11 0.01 0.04
a Individuals meeting criteria for 1–2 dependence symptoms but not abuse.
b For these analyses, withdrawal was excluded from the dependence criteria for cannabis, consistent with the DSM-IV formulation.
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issues as they relate to even rarely used illicit
drugs such as opiates and hallucinogens. Several
features of these results are noteworthy:
First, across all drug categories, correlations
between factors in two-factor solutions were
uniformly high (0.77–0.92) suggesting that a
one-factor model provided the most parsimoni-
ous representation of the inter-relationships be-
tween abuse and dependence criteria. There are
clear parallels between this ﬁnding and the ex-
isting literature (Hasin et al. 1988; Morgenstern
et al. 1994; Feingold & Rounsaville, 1995;
Nelson et al. 1999; Swift et al. 2001; Teesson
et al. 2002), yet this is one of the ﬁrst studies
both to include abuse symptomatology and to
extend such ﬁndings to illicit drug categories
other than cannabis.
Despite this, there were also clear departures
between DSM characterizations of symptom
severity and our empirical results. In particular,
the item referring to legal diﬃculties appeared to
represent an extreme form of problems (con-
trary to its designation as an abuse item in
DSM) while conversely, the dependence symp-
tom of wanting to cut down or quit appeared
to represent a relatively minor form of problem.
There are also several parallels between our re-
sults and those reported by Saha et al. (2006)
in an IRT analysis of alcohol abuse and de-
pendence criteria, based on the same sample
(NESARC) as the current analyses. Speciﬁcally,
Saha et al. (2006) concluded that the DSM
abuse and dependence criteria formed a single
continuum of severity with several of the abuse
criteria tapping into the relatively more severe
end of the continuum. They further questioned
the utility of the ‘ legal problems’ criterion and
concluded that their results did not support the
validity of the DSM distinction between abuse
and dependence.
An additional issue examined in these analy-
ses centered on the characteristics of ‘diagnostic
orphans’ (Hasin & Paykel, 1998, 1999; Pollock
& Martin, 1999; Sarr et al. 2000; Degenhardt
et al. 2002; Eng et al. 2003) and, more broadly,
the extent to which current abuse and depen-
dence conceptualizations are better represented
by a spectrum of severity (Helzer et al. 2006;
Muthen & Muthen, 2006). Again, perhaps the
most striking ﬁnding to emerge from these
analyses was the consistency of ﬁndings across
multiple drug classes. First, between 29% and
51% of all those who reported at least one
symptom of abuse or dependence did not meet
diagnostic criteria for abuse/dependence and
were therefore labeled as ‘orphans’. Despite not
receiving a diagnosis for a substance use dis-
order these individuals had elevated rates of
psychiatric disorder and were more similar to
individuals meeting criteria for abuse then they
Table 5. Mean number (with 95% conﬁdence limits) of co-morbid disorders according













Cannabis 0.70 1.45 1.84 2.20 2.14 3.45
(0.69–0.71) (1.41–1.49) (1.77–1.92) (2.13–2.28) (2.07–2.22) (3.30–3.60)
Cocaine 0.88 1.85 2.29 2.27 2.37 3.39
(0.85–0.87) (1.75–1.94) (2.15–2.43) (2.12–2.41) (2.41–2.52) (3.23–3.55)
Hallucinogens 0.86 2.14 2.40 2.63 2.98 3.82
(0.85–0.87) (2.05–2.24) (2.26–2.54) (2.45–2.81) (2.76–3.20) (3.50–4.15)
Opiates 0.87 2.18 2.40 2.58 2.71 3.97
(0.86–0.88) (2.07–2.28) (2.23–2.50) (2.36–2.79) (2.50–2.93) (2.68–4.26)
Stimulants 0.87 2.25 2.39 2.69 2.64 3.64
(0.86–0.88) (2.14–2.36) (2.20–2.37) (2.51–2.67) (2.46–2.82) (3.40–3.87)
Sedatives 0.88 2.07 2.55 2.88 2.92 3.69
(0.87–0.90) (1.97–2.18) (2.38–2.72) (2.65–3.13) (2.63–3.22) (3.36–4.01)
Tranquilizers 0.89 2.36 2.56 2.77 3.19 4.10
(0.88–0.90) (2.24–2.48) (2.37–2.75) (2.51–3.02) (2.81–3.48) (3.73–4.47)
Inhalants 0.92 2.54 3.04 2.77 3.33 4.36
(0.91–0.93) (2.38–2.69) (2.74–3.34) (2.38–3.16) (1.85–3.80) (3.65–5.07)
a Disorders include major depressive disorder, generalized anxiety disorder, panic disorder (with or without agoraphobia), speciﬁc phobias,
social phobia, antisocial personality disorder, alcohol abuse/dependence and nicotine dependence.
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were to those who had used drugs but reported
no symptoms of abuse or dependence.
Similarly, across drug classes, between 39%
and 49% of those receiving a diagnosis of abuse
also met criteria for 1–2 dependence symptoms
and these individuals had rates of psychiatric
disorder that were intermediate between those
who met criteria for abuse (only) and those
meeting criteria for dependence. Finally, it was
very rare for individuals who met criteria for
dependence not to also meet criteria for abuse:
between 74% and 94% of individuals meeting
criteria for dependence on any of the illicit drugs
also met criteria for abuse (although DSM’s
exclusion criteria preclude them from receiv-
ing a formal diagnosis of abuse). Consistent
with the existing literature (Regier et al. 1990;
Merikangas et al. 1998; Sakai et al. 2004;
Conway et al. 2006; Rodriguez-Llhera et al.
2006), individuals meeting criteria for illicit drug
dependence had the highest mean rates of psy-
chiatric disorders.
Several limitations of our analyses are note-
worthy: ﬁrst, we relied on retrospective reports
of lifetime symptomatology. However, Grant
et al. (1995), have previously reported on the
test–retest reliability of diagnostic criteria for
substances included in the AUDADIS and
found there to be good reliability for both abuse
and dependence criteria. Second, we did not test
for possible sex diﬀerences in item function
across the eight drug classes. We have pre-
viously reported diﬀerential item function in
women and men for cannabis use disorders
(Agrawal & Lynskey, in press) while Saha et al.
(2006) have examined this issue with respect
to alcohol use disorders. The eﬀects of ad-
ditional covariates, such as birth cohort or race/
ethnicity were also not examined in the present
study. Finally, data are also not available on
the concurrent or simultaneous use of diﬀerent
drug categories, despite the fact that such use
is common (Earleywine & Newcomb, 1997;
Collins et al. 1998). Thus, we are uncertain
about the extent to which the experience – and
item function – of abuse and dependence cri-
teria may be inﬂuenced by the concomitant use
of multiple drug classes.
The results of our study, while generalizable
to U.S. populations, are restricted only to sam-
ples of individuals who have used the respective
psychoactive substance at least once in their
lifetime. While this may introduce some stat-
istical bias (i.e. due to the correlation between
lifetime use and liability to endorse symptoms of
abuse/dependence, with this correlation varying
across samples), it does not aﬀect the analyses
from a psychometric perspective. The properties
of abuse and dependence criteria cannot be as-
sessed in samples of never users as they are, by
contingency, missing at random in such indi-
viduals.
On the other hand, several elegant statistical
methods currently exist for the investigation of
such conditional multi-stage processes (Kendler
et al. 1999; Heath et al. 2002; Neale et al. 2006).
While dependent on the availability of reason-
able measures of substance use and, critically,
on underlying distributional assumptions (e.g.
multivariate normality), these methods can
successfully estimate the correlated liability
structure of substance use and substance use
disorders. Although conceptually intriguing,
such multi-stage analyses are not directly rel-
evant to the psychometric properties of DSM
criteria, which only relate to the latter stage of
substance-related behavior.
One further issue requiring brief comment is
our inclusion of withdrawal in the criteria set for
the IRT analyses of cannabis use disorder
symptomatology. Currently, DSM-IV excludes
withdrawal from cannabis use disorders al-
though recent evidence from both epidemi-
ological and carefully controlled laboratory
studies has conﬁrmed that there is indeed a
withdrawal syndrome associated with cessation
of cannabis use (see review by Budney et al.
2004). Our own analyses indicated both that
withdrawal loads highly on a factor representing
liability to cannabis use disorders and that it has
relatively high diﬃculty, consistent with evi-
dence that, relative to some other drug categor-
ies, cannabis withdrawal is relatively mild and
likely to occur only in those with a history of
prolonged, heavy use. For consistency with the
DSM system, we did, however, exclude with-
drawal from the dependence set for cannabis in
our consideration of diagnostic orphans.
In summary, our analyses have utilized the
power of NESARC’s exceptionally large sample
to examine a number of issues relating to
the assessment of illicit drug use disorders.
While such issues have been relatively under-
explored in research on illicit drugs (other
Psychometric properties of illicit drug abuse/dependence 1353
than cannabis), our results generally conﬁrmed
previously reported patterns for alcohol and
cannabis use and have broad implications
for the nosology of substance use disorders.
In particular, consideration of item diﬃculty
suggested important departures between DSM
conceptualizations and item performance.
Speciﬁcally, several items hypothesized to indi-
cate relatively minor forms of disorder (abuse)
had high item diﬃculty, several dependence
criteria had low item diﬃculty and may be better
conceptualized as representing less severe forms
of disorder. While these ﬁndings suggest the
need for alterations in speciﬁc criteria, ﬁndings
that a relatively high proportion of all individ-
uals meeting criteria for one or two dependence
criteria do not meet criteria for abuse –but
nonetheless experience elevated rates of pro-
blems – also suggest that it may be important to
revise either the item set or the diagnostic
classiﬁcation to more adequately represent the
range of severity in symptomatology.
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